Rehabilitation therapy in multiple sclerosis;Tratamiento rehabilitador en la esclerosis múltiple

Revista de Neurologia

Volumn 44, Issue 7, 2007, Pages 426-431

  Terré Boliart, Rosa ^a   Orient Lopez F ^a  

^a University Institute affiliated with the Autonomous University of Barcelona   (Spain)

Author keywords

Deficit; Disability; Effectiveness; Handicap; Multiple sclerosis; Rehabilitation

Indexed keywords

AMANTADINE; BACLOFEN; BETHANECHOL; CARBAMAZEPINE; CLONAZEPAM; DESMOPRESSIN; DIAZEPAM; ISONIAZID; MODAFINIL; OXYBUTYNIN; PROPANTHELINE BROMIDE; PROPRANOLOL DERIVATIVE; TIZANIDINE;

ATAXIA; DISEASE COURSE; DRUG DOSE INCREASE; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; MYALGIA; RATING SCALE; REHABILITATION CARE; REVIEW; SPASTICITY; SYMPTOM; URINARY URGENCY; PATHOPHYSIOLOGY; QUALITY OF LIFE; TREATMENT OUTCOME;

ATAXIA; DISEASE PROGRESSION; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34848875756     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4407.2005546     Document Type: Review

References (57)

1. Fernández O. Epidemiología de la esclerosis múltiple en España. In Alfaro A, Sancho J, eds. Neuroepidemiología. Madrid: MCR; 1990. p. 115-22.
2. Cobble ND, Grigsby J, Kennedy PM. Rehabilitation of the patient with multiple sclerosis. In DeLisa JB, ed. Rehabilitation medicine: principles and practice. Philadelphia: Lippincott; 1993. p. 861-85.
3. Carton H, Loos R, Pacolet J, Versieck K, Vlietinck R. Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium). J Neurol Neurosurg Psychiatry 1998; 64: 444-50.
4. Thompson A. The effectiveness of neurological rehabilitation in multiple sclerosis. J Rehabil Res Dev 2000; 37: 455-61.
5. Hughes R. Modulating the immune response in demyelinating diseases. J Neurol Neurosurg Psychiatry 1998; 64: 148.
6. Thomson AJ, Colville PL, Ketelaer P, Paty DW. Long-term management of multiple sclerosis. MS Management 1994; 1: 1-8.
7. Kidd D, Thompson AJ. Prospective study of neurorehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 423-4.
8. Freemann JA, Langdon DW, Thomson AJ. Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 1999; 50: 50-6.
9. Langhorne P, Martin D. Stroke units: an evidence based approach. London: BMA House; 1998.
10. Thompson A. Progress in neurorehabilitation in multiple sclerosis. Curr Opin Neurol 2002; 15: 267-70.
11. Aisen ML, Sevilla D, Fox N. Inpatient rehabilitation for multiple sclerosis. J Neurol Rehabil 1996; 122: 871-82.
12. World Health Organization. ICDH-2. International classification of impairments, activities and participation: a manual of dimensions of disablement and functioning. Geneva: WHO; 1997.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
14. Granger CV, Cotter AC, Hamilton BB, Fiedler RC, Hens MM. Functional assessment scales: a study of persons with multiple sclerosis. Arch Phys Med Rehabil 1990; 71: 870-5.
15. Ko Ko C. Effectiveness of rehabilitation for multiple sclerosis. Clin Rehabil 1999; 13: 33-41.
16. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004; 8:1-48.
17. Societies IFoMS. Minimal record on disability. Acta Neurol Scand 1994; 101: S169-217.
18. Harwood RH, Dickinson E, Ebrahin S. The London Handicap Scale: a new outcome measure for chronic disease. Qual Health Care 1994; 3: 11-6.
19. Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, Johnson MH. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil 2001; 15: 247-58.
20. LaRocca NG. Efficacy of rehabilitation in multiple sclerosis. J Neurol Rehabil 1995; 6: 147-55.
21. Petajan JH, White CM, Spencer MK, Mino L, Hicks EW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996; 39: 432-41.
22. Fuller KJ, Wiles CM. Physiotherapy in chronic multiple sclerosis: a controlled trial. Clin Rehabil 1996; 10: 195-204.
23. Lord SE, Wade DT, Halligan PW. A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study. Clin Rehabil 1998; 12: 477-86.
24. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999; 52: 57-62.
25. Patti F, Ciancio MR, Cacopardo M, Reggio E, Fiorilla T, Palermo F, et al. Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients, randomised controlled trial. J Neurol 2003; 250: 861-6.
26. Liu C, Playford ED, Thompson AJ. Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 2003; 250: 1214-8.
27. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 2002; 249: 1027-33.
28. Freemann JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997; 42: 236-44.
29. Francabandera FL, Holland NJ, Wiesel-Levison P, Scheinberg LC. Multiple sclerosis rehabilitation: inpatient vs. outpatient. Rehabil Nurs 1988; 13: 251-3.
30. Di Fabio RP, Choi T, Hansen CR, Shapiro RT. Extended outpatient rehabilitation: its influence on symptom frequency, fatigue and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998; 79: 141-6.
31. Thompson AJ. Symptomatic treatment in multiple sclerosis. Curr Opin Neurol 1998; 11: 305-9.
32. Leary SM, Thompson AJ. Current management of multiple sclerosis. Int J Clin Pract 2000; 54: 161-9.
33. Polman CH, Murray TJ. Multiple sclerosis. The guide to treatment and management. 5 ed. New York: Demos; 2001.
34. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis. Evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.
35. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956-61.
36. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956-61.
37. Rammohan KW, Rosenberg JH. Modafinil-efficiency and safety for treatment of fatigue in patients with multiple sclerosis. Neurology 2000; 54: S24.
38. Ko Ko C, Ward AB. Management of spasticity. Br J Hosp Med 1997; 58: 400-5.
39. Multiple Sclerosis. Consensus Conference organized by the French Federation for Neurology. Rev Neurol (Paris) 2001; 157: 713-21.
40. Nance PW, Sheremata WA, Lynch SG, Vollmer T, Hudson S, Francis GS, et al. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis. Arch Neurol 1997; 54: 731-6.
41. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-9.
42. Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-32.
43. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990; 28: 512-5.
44. Alusi SH, Glickman S, Aziz TZ, Bain PG. Tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999; 66: 131-4.
45. Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, Van Someren EJ, De Bie RM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000; 342: 461-8.
46. Montgomery EB Jr., Baker KB, Kinkel RP, Barnett G. Chronic thalamic stimulation for the tremor of multiple sclerosis. Neurology 1999; 53: 625-8.
47. Whittle IR, Hooper J, Pentland B. Thalamic deep-brain stimulation for movement disorders due to multiple sclerosis. Lancet 1998; 351: 109-10.
48. Multiple Sclerosis Council for Clinical Practice Guidelines. Urinary dysfunction and multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1999
49. Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 245-50.
50. Kinn AC, Larsson PO. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24: 109-12.
51. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 1996; 53: 1270-5.
52. Feigenson JS, Scheinberg L, Catalano M, Polkow L, Mantegazza PM, Feigenson WD, et al. The cost-effectiveness of multiple sclerosis rehabilitation: a model. Neurology 1981; 31: 1316-22.
53. Greenspun B, Stineman M, Agri R. Multiple sclerosis and rehabilitation outcome. Arch Phys Med Rehabil 1987; 68: 434-7.
54. Carey RG, Seibert JH, Posavac EJ. Who makes the most progress in inpatient rehabilitation? An analysis of functional gain. Arch Phys Med Rehabil 1988; 69: 337-43.
55. Kidd D, Losseff NA, Thomson AJ. The benefit of inpatient neurorehabilitation in multiple sclerosis. Clin Rehabil 1995; 9: 198-203.
56. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 2002; 8: 161-8.
57. Pozzilli C, Brunetti M, Amicosante AM, Gasperini C, Ristori G, Palmisano L, et al. Home based management in multiple sclerosis: results of a randomised controlled trial. J Neurol Neurosurg Psychiatry 2002; 73: 250-5.